Skip to main content
. 2009 Apr 13;29(12):3319–3331. doi: 10.1128/MCB.01803-08

TABLE 3.

Patient survival in the combined 395-profile data set

Patients n No. dead from cancer (%) Mean survival time (yr)
All 395 84 (21) 10.6
HER2 positive 44 16 (36) 8.2
HER2 negative 351 68 (19) 10.8
Grade 3 112 33 (29) 9.4
Not grade 3 283 51 (18) 11.0